What’s trending in pharmacovigilance? New podcast episode

Perspective / 21 December 2023

In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.


WHAT DID THE DRUG SAFETY COMMUNITY ACHIEVE IN 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance, to walk us through current and future trends in pharmacovigilance.

Among her predictions, hear her thoughts on patient engagement – a hot topic that is going to get hotter – as well as the challenges she foresees closest to home in Latin America.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

Related Articles

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

Risk is in the eye of the beholder when it comes to communication

Risk Communications in Healthcare – Bridging the Gap

You may also like

Risk is in the eye of the beholder when it comes to communication

Are you and your patient talking about the same thing when you discuss risk? Most likely not, and understanding this is key to effective risk communication.

Perspective / 18 March 2024

Risk Communications in Healthcare – Bridging the Gap

Effective risk communication is a mainstay of successful pharmacovigilance, yet examples of poor risk mitigation abound. Where are we failing, and what can be done about it?

Perspective / 20 November 2023

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?

Perspective / 23 September 2024